The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global craniomaxillofacial (CMF) devices market is expected to exhibit a CAGR of XX% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Craniomaxillofacial (CMF) devices refer to the equipment used during orthopedic surgeries. These devices are used for the treatment of severe cranial and facial bone injuries using medical implants. Some of the commonly available CMF implants include cranial flap fixtures, bone-graft substitutes, screws and bolts, which are used for CMF distraction, thoracic fixation and temporomandibular joint replacement. These devices are manufactured using metals, such as steel and titanium, bioabsorbable polymers, ceramics, etc., and are also used in neurosurgery, plastic surgery, orthognathic and dental surgeries.
The increasing incidences of cranial fractures, along with the growing demand for minimally invasive (MI) facial reconstruction surgeries, is one of the key factors driving the growth of the market. There is widespread adoption of CMF devices as they aid in faster recovery, the small size of incisions and minimal complications post-surgery. They are also used for the treatment of neuro-oncology, neurovascular, spinal and trans-nasal skull-based injuries. Furthermore, the increasing adoption of deep brain stimulation procedures across the globe is also providing a boost to the craniomaxillofacial devices market growth. In these procedures, CMF implants are used to cover the skull after inserting the electrode. Additionally, various technological innovations, including the utilization of 3D printed implants, along with the introduction of titanium cranial fixation systems that have a lower risk of infection, are also creating a positive impact on the market. Other factors, including the rising geriatric population, growing awareness regarding treatment options for cranial fractures, increasing consumer expenditures and developing healthcare infrastructure across the globe, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global craniomaxillofacial (CMF) devices market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, material type, application, fixator type and end-user.
Breakup by Product Type:
Breakup by Material Type:
Breakup by Application:
Breakup by Fixator Type:
Breakup by End-User:
Brealup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Integra Lifesciences Corporation, Johnson & Johnson Medical Devices Companies (JJMDC), KLS Martin, Medartis AG, Medtronic Inc., OsteoMed, Stryker Corporation, TMJ Concepts, Zimmer Biomet Inc., etc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product Type, Material Type, Application, Fixator Type, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Integra Lifesciences Corporation, Johnson & Johnson Medical Devices Companies (JJMDC), KLS Martin, Medartis AG, Medtronic Inc., OsteoMed, Stryker Corporation, TMJ Concepts and Zimmer Biomet Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at